M8 Alliance Executive Committee
João Gabriel Silva
Rector, University of Coimbra, Portugal
Chairman of the Board of Directors, Coimbra University Hospitals, Portugal
Charité - Universitätsmedizin Berlin, Germany
Incoming International President
Chancellor, Tehran University of Medical Sciences, Iran
Former International President
Dean, Faculty of Medicine, University of Montreal, Canada
Axel Radlach Pries
Dean of Host Institution
Charité - Universitätsmedizin Berlin, Germany
Michael J. Klag
Strategic Co-operation and Stakeholder Liaison
Former Dean, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
Governance and Fundraising
Head, School of Medicine, University of Tasmania, Australia
José Otávio Auler Jr.
Officer at large
Dean, University of São Paulo, Faculty of Medicine, Brazil
Heads of Delegations
Christina Mitchell trained as a physician scientist specializing in clinical hematology. Her work for the last twenty years has focused on characterizing the function of unknown genes that regulate cell proliferation and growth, and when mutated or deleted lead to human disease.
José is specialized in anesthesiology and in intensive care. His clinical research activities focus on fluid restitution, hemodynamic monitoring, mechanical ventilation, sepsis, patients at high surgical risk and experimental hemodilution.
José Eduardo Krieger is Professor of Genetics and Molecular Medicine at the University of São Paulo Medical School and Director of the Laboratory of Genetics & Molecular Cardiology at the Heart Institute (InCor). He is the President of the State of Sao Paulo Academy of Science and regular member of the Brazilian Academy of Science.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She was the International President of the World Health Summit 2017.
He holds the Canada Research Chair in Hematopoiesis and Immune Cell Differentiation and is Full Research Professor at the University of Montreal and Adjunct Professor at McGill University. Until 2006, he held several senior management positions in Germany. He is member of the Board of Directors of the Canadian Society for Molecular Biosciences (CSBM) and Research Canada.
Professor Cao Xuetao major interests are immunobiology of APCs (dendritic cells, macrophages), TLR signaling and immune regulation, cancer immunotherapy and gene therapy. In recent years he is investigating the mechanisms for immune recognition and TLR signaling.
Professor Depei Liu's central research interests are medical molecular biology and research in gene regulation. He executes various prestigious positions, including former President of the Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC).
Professor Gérard Friedlander focused his experimental and clinical research on the molecular basis of phosphate homeostasis in health and disease, and on the cellular mechanisms underlying the progression of renal lesions during chronic kidney disease. Special fields of his interests and expertise are the links between clinical practice, clinical investigation, experimental and translational research and medical education.
Alumnus of Ecole Polytechnique and of AgroParisTech and PhD graduate of Claude Bernard University, Lyon, and former chairman and CEO of the French National Institute of Agricultural Research (Inra), he is now the acting President of Université Sorbonne Paris Cité (USPC).
Professor Karl Max Einhäupl is a trained Neurologist. In 2004, he was awarded the German Federal Cross of Merit. From 1993-2008 Director of the Clinic for Neurology, Charité - Universitätsmedizin Berlin and from 2007 to 2008 Head of the Centre “CC15: Neurology, Neurosurgery and Psychiatry”. Since 2008, he is Chief Executive Officer of the Charité - Universitätsmedizin Berlin.
Axel R. Pries is a Professor of Physiology and Dean of the Charité - Universitätsmedizin Berlin. His major research fields are microcirculation, organ perfusion, endothelial function, endothelial surface, vascular adaptation, angiogenesis, tumor microcirculation and blood rheology.
After graduating from Tehran University of Medical Sciences (TUMS) in 1992, he was appointed as faculty member in the General Surgery department in 1999. His focus of research are Hepatopancreatobiliary Surgery and Liver Transplantation. He was executive advisor for the Chancellor of TUMS from 2005-2008, Dean of the Medical School from 2008-2009, Vice Chancellor from 2009-2011, and appointed as Chancellor in 2013.
As Deputy Acting Minister for International Affairs at the Ministry of Health and Medical Education, he is in charge of overseeing the relationship between the Iranian health system, UN agencies and all international and global organizations. Since February 2015, he is the communication focal point from Eastern Mediterranean region at the Board of the Global Fund to fight Aids, Tuberculosis and Malaria, Geneva, Switzerland. He has a research track record in health policy analysis in the field of primary care, global health, non-communicable diseases, universal health coverage, and eHealth.
After conducting research on Human Anatomy at Sapienza University from 1983 to 1986, Eugenio Gaudio began teaching at the University of L’Aquila in 1987 and served as Dean of the Faculty of Medicine and Surgery from 1997 to 2000. He returned to Sapienza as a Professor of Human Anatomy. From 2008 to 2010, he was Director of the Department of Human anatomy. Since 2010, he has been President of the Faculty of Pharmacy and Medicine and President of the Permanent Conference of Italian Faculties and Schools of Medicine and Surgery.
He is author of more than 200 scientific articles published in international journals and coordinator of several research projects in the field of pharmacology. He has extensive experience in international relations and he is currently Vice-Rector for European University Networks of Sapienza University and President of the UNICA network of the Universities from the Capitals of Europe.
Shunichi Fukuhara received his clinical training at the University of California at San Francisco, and was board-certified in Internal Medicine. He practices cardiology in Japan. His main research interests are clinical evaluative research and health services research. In 2000, Fukuhara founded Kyoto University’s Department of Healthcare Epidemiology.
A full professor at the Faculty of Medicine of the University of Coimbra since 2004, he runs the Genetics Service there, teaches Genetics in the Integrated Masters and is a member of the Scientific Council. He is the titular academic of the XL chair, of the Portuguese Academy of Medicine.
After coordinating the work on the first Portuguese computer, designed and produced industrially in Portugal, he became one of the founders of the Center for Informatics and Systems of the University of Coimbra. Almost uninterrupted, he participated in the University's management since joining the University of Coimbra in 1975.
Professor Ivan Dedov is the president of the Russian Academy of Medical Sciences and a member of the Russian Academy of Sciences. He devoted much time to fundamental and applied problems of endocrinology and is one of eminent organizers in medical science in Russia.
Professor Evgeniy I. Sidorenko is a member of the Russia State Medical Academy and President of the Russian Pediatrics Ophthalmology Association. His scientific activity is mainly devoted to the use of infrasound in medical practice; hypoxia and its role in ophthalmopathology; retinopathy of prematurity; refractive surgery; laser therapy; and surgery.
Professor John Eu-Li Wong is a medical oncologist-haematologist. He is actively involved in the development of Biomedical Sciences as a key pillar of Singapore's economy, as well as the development of Singapore's first Academic Health System linking the National University Hospital and the National University of Singapore's medical, public health, dental, and nursing schools under one unified governance.
Professor Yeoh's research interest is in the early detection of gastric and colorectal cancers. He is the Lead Principal Investigator of the Singapore Gastric Cancer Consortium, a national flagship research group. He also chairs the National Colorectal Cancer Screening Committee of the Health Promotion Board, Ministry of Health.
He is a statistician and obtained a First Class Honors degree from the Imperial College, UK, graduating top of his cohort on a Singapore Government Scholarship awarded by the Public Service Commission. He has gained international recognition for his work in genomics. He has developed several landmark statistical methods and genomic databases, and these have elevated genomics research in Singapore to international standards.
Professor Henri Bounameaux is director of the Division of Angiology and Haemostasis, and chairman of the Department of Medicine at the University Hospitals of Geneva. His research interests include all aspects of venous thromboembolism.
A professor of Public Health at University Descartes, Sorbonne Paris Cité, he is chair of the Centre Virchow Villermé de Santé Publique Paris-Berlin, co-chairs the European Academic Global Health Alliance, is president of the European Agency for Public Health Education Accreditation and Founding Director of the Institute of Global Health, University of Geneva. In 2016, Antoine Flahault was the International President of the World Health Summit.
As a leading contributor to academic and political debates on governance for health at a national and global level, Ilona Kickbusch conducts global health diplomacy seminars in many regions and advises the World Health Organization (WHO). In Switzerland, she serves on the executive board of the Careum Foundation and as an advisor for Health 2020.
Lawer by training, he worked at the International Committee of the Red Cross on field missions as delegate, chief of under-delegation, legal advisor for Asia and Latin America, representative of the ICRC at the United Nations in New York, and was in charge of policies for the disabled and substance dependence. In 2004, he became Director General of the Hospice General. In 2013 he was appointed new Director General of the Geneva University Hospitals.
Trained in Internal Medicine and Nephrology in Switzerland, Australia, France, and the UK, she is still active as a Senior Consultant of Nephrology at the HUG and a member of the Swiss and the Paris Medical Association. She also holds a Master of Business Administration (MBA) degree from the University of Geneva with a focus on Health Economy and Policies.
Parallel to his current position as Associate Dean, Chang-Chuan Chan is also joint-appointed Investigator of the Division of Environmental Health and Occupational Medicine, National Health Research Institutes. He is a known expert for topics like air pollution, epidemiological studies on industrial pollution and global health research.
A trained historian, he is Rector of the Istanbul University and Chairman of the Board of Overseers of the Haliç University.
Educated in Istanbul University Medical School, he is a specialist for internal medicine and the research on allergies.
Charles Ibingira, is a Ugandan surgeon, academic and medical administrator. He was appointed Principal of Makerere University College of Health Sciences in November 2015. He has previously served as the Dean of Makerere University School of Biomedical Sciences, from 2010 until 2014.
Peter Piot was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, as well as the Associate Director of the WHO Global Programme on AIDS. He was a co-discoverer of the Ebola virus, and his research focuses upon HIV/AIDS, sexually transmitted infections, and women’s health.
Professor Elio Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC). In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC). He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005. He was rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009.
A world renowned kidney disease epidemiologist, his scientific contributions have aided in the prevention and epidemiology of kidney disease, hypertension and cardiovascular disease. He led pioneering studies in kidney disease epidemiology, including the first study to assess the incidence of end-stage renal disease and to identify blood pressure as a risk factor for the development of kidney failure.
A nationally renowned researcher and a veteran academic leader, her research focuses on the impact of health services and policies on the short-and long-term consequences of traumatic injury. She has contributed to the development and evaluation of tools for measuring both the severity and outcome of injury which have been used to evaluate the organization, financing and performance of trauma systems and rehabilitation services.
Professor Valdivia is co-Director and founder of the Global Health Programme of the School of Public Health, University of Chile. Previously, he chaired the School’s Department of Health Promotion and Education (2005-2010). He completed a successful career in international development cooperation in the United States, having worked for UNFPA, PAHO/WHO, IPPF, and USAID.
Professor Steven A. Wartman is a internist, sociologist and Master of the American College of Physicians. Since 2005, he is the 3rd President of the Association of Academic Health Centers (AAHC), a non-profit association based in Washington, DC, that seeks to advance health and well-being through leadership of the multifaceted institutions that educate the next generation of health professionals.
From 2006-2013, Professor Atun was Head of the Health Management Group at Imperial College London. From 2008-2012 he served as a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis and Malaria as the Director of Strategy, Performance and Evaluation Cluster. His research focuses on the design and implementation of health systems transformations and their impact on outcomes.
Ben Canny is Head of the School of Medicine at the University of Tasmania, where he has responsibility for Medicine, Pharmacy and Paramedicine. Prior to this he was the convenor of the Medical Degree at Monash University. Ben has always had a vital interest in Medical Education and Medical Science, and has led the Medical Education initiative of the M8 Alliance. At present, he is leading the development of a harmonized curriculum of Global Health Education for Health Professionals to be shared by members of the M8 Alliance. He is also Vice-President of the Australian and New Zealand Associate for Health Professional Educators.